Representative Mike Kelly of Pennsylvania sold Bristol-Myers Squibb (NYSE: BMY) stock worth between $16,002 and $65,000, with the transaction occurring on May 7, 2026. This sale was filed in June 2026. Congressional transactions, while not primary investment advice, can offer insights into a stock's potential performance for investors.

Senator Gary C. Peters from Michigan recently purchased between $1,001 and $15,000 worth of Kraft Heinz (NASDAQ: KHC) stock, with the transaction occurring on May 21, 2026. This purchase is part of his 23 stock transactions totaling over $135,000 in the last three years. Congressional transactions, while not primary investment advice, offer insight into potential stock movements as representatives are required to disclose their trades.

Robert K. Shearer, a Director at Church & Dwight Co (NYSE: CHD), recently exercised stock options for 8,600 shares, valuing the transaction at $169,850 based on current share prices. This information was disclosed in an SEC filing. The article also provides a financial overview of Church & Dwight Co, highlighting its revenue growth, profitability indicators, valuation metrics, and the significance of insider transactions.

Sandra Volpe, a Director at Republic Services (NYSE: RSG), sold 1,800 shares of the company's stock for a total value of $380,304 on June 12. The article provides a closer look at Republic Services's financial performance, including revenue growth and debt management, and analyzes its market valuation. It also explains the significance of insider activity in investment decisions.

John C. Morris, EVP & CTO at Seagate Technology Hldgs (NASDAQ: STX), sold 573 shares of the company stock worth $471,426 on June 11. Seagate's shares are up 5.37% at $914.68. The article also provides a financial overview of Seagate, highlighting its revenue growth, debt management challenges, and market capitalization, along with an explanation of insider transactions.

PulteGroup, a major U.S. homebuilder, is under investor scrutiny due to its valuation metrics, the broader housing market, and prevailing interest rates. The company's performance is driven by the cyclical nature of homebuilding, influencing its P/E and P/B ratios, and its ability to convert land into cash-generating communities. Key factors for investors include interest rate trajectories, housing data, pricing trends, economic indicators, and the company's capital allocation decisions.

Medtronic plc (NYSE: MDT) has finalized its acquisition of Scientia Vascular for $550 million, plus potential earn-out and milestone payments. This strategic move integrates Scientia's advanced guidewires and catheters with Medtronic's neurovascular products, aiming to simplify complex neurovascular procedures and enhance treatment for conditions like stroke. The acquisition is expected to be minimally dilutive to Medtronic's adjusted EPS in FY27 and accretive thereafter, strengthening Medtronic's leadership in neurovascular care.

Morgan Stanley has downgraded two life sciences REITs, Healthpeak Properties (DOC) and Alexandria Real Estate Equities (ARE), citing limited visibility into the lab market's recovery. Despite some positive data points regarding leasing and supply, the investment bank views their recent stock run-ups as unsupported given the uncertainties.

Capital Clean Energy Carriers Corp. (CCEC) has formed a joint venture with CMA CGM S.A. to build and operate a 20,000 cbm dual-fuel LNG bunkering vessel. This marks CCEC's entry into the LNG bunkering segment, with the vessel slated for delivery in Q3 2028 and a 12-year time charter expected with a joint venture of CMA CGM and TotalEnergies S.A. The initiative aims to provide reliable marine fuel supply, support decarbonization efforts in the shipping industry, and create a new revenue stream for CCEC.

Dollar General (DG) shares are showing a technical turnaround after bottoming out at $100 three weeks ago, despite a prevalent "Sell" rating from Barchart. The deep-discount retailer, valued at $24 billion, is known for its resilience during inflationary periods as consumers "trade down." Analysts have a "Moderate Buy" consensus for DG, with price targets ranging from $90 to $175, suggesting a potential for significant upside from its current levels.